Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 1,356 Cr.
- Current Price ₹ 750
- High / Low ₹ 1,037 / 262
- Stock P/E 59.1
- Book Value ₹ 60.1
- Dividend Yield 0.00 %
- ROCE %
- ROE 41.7 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 12.5 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 77 | |
| 51 | |
| Operating Profit | 26 |
| OPM % | 33% |
| 0 | |
| Interest | 3 |
| Depreciation | 1 |
| Profit before tax | 22 |
| Tax % | 25% |
| 16 | |
| EPS in Rs | 11.88 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 42% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 13 | 18 |
| Reserves | 25 | 91 |
| 27 | 47 | |
| 13 | 21 | |
| Total Liabilities | 78 | 176 |
| 14 | 13 | |
| CWIP | 6 | 15 |
| Investments | 3 | 3 |
| 55 | 145 | |
| Total Assets | 78 | 176 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| -10 | |
| -23 | |
| 33 | |
| Net Cash Flow | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | 127 |
| Inventory Days | 141 |
| Days Payable | 40 |
| Cash Conversion Cycle | 228 |
| Working Capital Days | 129 |
| ROCE % |
Documents
Announcements
-
Shareholders meeting
12 February 2026 - 12 Feb 2026 EGM approved ratification and variation in IPO proceeds utilisation; 62.10% turnout; unanimous approval.
-
Shareholders meeting
12 February 2026 - EGM on Feb 12, 2026 to consider ratification and variation in IPO proceeds utilization (special resolution).
-
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
11 February 2026 - MDSAP certification (OPINION 0090436/26-6), four-year GMP approval enabling Class III device sales in Brazil.
-
Updates
6 February 2026 - Participating in World Health Expo (WHX) in Dubai, 9-12 February 2026.
-
Updates
4 February 2026 - MDSAP certificate presentation Feb 06, 2026 2:00 PM IST at Noida; MD Anupam Ghosh received.
Annual reports
No data available.
Business Profile[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.